Sanofi SNY
$47.04 +$0.13 (+0.28%)
Market closed · Nov 7, 9:10 am ET · Last extended-hours $46.12 -1.96%
Open$45.63
Prev close$46.91
Day range$45.58 – $47.16
Volume3.90M
Market cap$112.71B
P/E (TTM)24.1
Dividend yield4.99%
SNY Stock News
Headlines matching Sanofi or the SNY ticker, most recent first.
- Sanofi (SNYNF) Gets a Hold From J.P. Morgan
- RBC Capital Initiates SANOFI(SNYNF.US) With Hold Rating, Announces Target Price $93.06
- Barclays Maintains SANOFI(SNYNF.US) With Hold Rating, Cuts Target Price to $96.55 Negative
- BofA Securities Maintains SANOFI(SNYNF.US) With Hold Rating, Maintains Target Price $106.9
- Sanofi's (SNY.US) BTK inhibitor approved for market launch in China Positive
- Deutsche Bank Maintains SANOFI(SNYNF.US) With Buy Rating, Cuts Target Price to $107.69 Negative
- Deutsche Bank Maintains SANOFI(SNYNF.US) With Buy Rating, Raises Target Price to $110.07 Positive
- UBS Maintains SANOFI(SNYNF.US) With Hold Rating
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)
- RBC Capital Maintains SANOFI(SNYNF.US) With Hold Rating, Cuts Target Price to $92.32 Negative
- Deutsche Bank Maintains SANOFI(SNYNF.US) With Buy Rating, Cuts Target Price to $109.63 Negative
- HSBC Maintains SANOFI(SNYNF.US) With Buy Rating, Raises Target Price to $116.12 Positive
- Sanofi (SNY.US) has submitted a new indication for its long-acting RSV monoclonal antibody for marketing approval. Positive
- TD Cowen Maintains Sanofi(SNY.US) With Hold Rating, Maintains Target Price $57
- Deutsche Bank Maintains SANOFI(SNYNF.US) With Buy Rating, Cuts Target Price to $110.87 Negative
No comments yet — be the first to weigh in on SNY.
Sign in to join the discussion.